Important Drug Safety Update from the MHRA on Valproate and pregnancy

24th April 2018

The MHRA have issued new guidance stating that Valproate medicines (Epilim▼, Depakote▼) are contraindicated in women and girls of childbearing potential unless a Pregnancy Prevention Programme is in place.

Read the full update here: https://www.gov.uk/drug-safety-update/valproate-medicines-epilim-depakote-contraindicated-in-women-and-girls-of-childbearing-potential-unless-conditions-of-pregnancy-prevention-programme-are-met

More News

1 million SCRIPT module completions 

We are delighted to announce that, as of February 2024, one million SCRIPT modules have been successfully completed by users!  There are more active users and module completions than ever before. Since the start of SCRIPT in 2010, the programme has significantly...